| James Russell Bell, MD | |
|
1100 35th St, Marion, IA 52302-1710 | |
| (319) 377-4844 | |
| (319) 377-0852 |
| Full Name | James Russell Bell |
|---|---|
| Gender | Male |
| Speciality | Hospice/palliative Care |
| Experience | 41 Years |
| Location | 1100 35th St, Marion, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528044310 | NPI | - | NPPES |
| 9041384 | Medicaid | IA | |
| 80086945 | Other | IA | RR MEDICARE |
| 3041384 | Medicaid | IA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207QA0000X | Family Medicine - Adolescent Medicine | 24258 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St Lukes Hospital | Cedar rapids, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Lukes Methodist Hospital | 6608786751 | 66 |
News Archive
Mary Ellen Stanton, a senior maternal health advisor at USAID, and Chris Thomas, global health communications and policy advisor at USAID, outline the agency's work to promote better health outcomes for women and children in the developing world on GlobalPost's "Global Pulse" blog.
Patients with chemotherapy-refractory small-cell lung cancer may benefit from treatment with the topoisomerase II inhibitor amrubicin, research from Japan suggests.
IMDx today announced that they have signed a multi-year agreement with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays for the Abbott Molecular FDA cleared, m2000 instrument system to be distributed worldwide. Financial terms have not been disclosed.
ARYx Therapeutics, Inc. today announced that it has secured bridge financing to allow ARYx time and resources to potentially complete a transaction that could create significant value for stockholders. ARYx also released its financial results for the second quarter of 2010.
› Verified 1 days ago
| Entity Name | Iowa Physicians Clinic Medical Foundation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1366425274 PECOS PAC ID: 8729992318 Enrollment ID: O20031118000363 |
News Archive
Mary Ellen Stanton, a senior maternal health advisor at USAID, and Chris Thomas, global health communications and policy advisor at USAID, outline the agency's work to promote better health outcomes for women and children in the developing world on GlobalPost's "Global Pulse" blog.
Patients with chemotherapy-refractory small-cell lung cancer may benefit from treatment with the topoisomerase II inhibitor amrubicin, research from Japan suggests.
IMDx today announced that they have signed a multi-year agreement with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays for the Abbott Molecular FDA cleared, m2000 instrument system to be distributed worldwide. Financial terms have not been disclosed.
ARYx Therapeutics, Inc. today announced that it has secured bridge financing to allow ARYx time and resources to potentially complete a transaction that could create significant value for stockholders. ARYx also released its financial results for the second quarter of 2010.
› Verified 1 days ago
| Entity Name | St Lukes Methodist Hospital |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073553939 PECOS PAC ID: 6608786751 Enrollment ID: O20040204000942 |
News Archive
Mary Ellen Stanton, a senior maternal health advisor at USAID, and Chris Thomas, global health communications and policy advisor at USAID, outline the agency's work to promote better health outcomes for women and children in the developing world on GlobalPost's "Global Pulse" blog.
Patients with chemotherapy-refractory small-cell lung cancer may benefit from treatment with the topoisomerase II inhibitor amrubicin, research from Japan suggests.
IMDx today announced that they have signed a multi-year agreement with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays for the Abbott Molecular FDA cleared, m2000 instrument system to be distributed worldwide. Financial terms have not been disclosed.
ARYx Therapeutics, Inc. today announced that it has secured bridge financing to allow ARYx time and resources to potentially complete a transaction that could create significant value for stockholders. ARYx also released its financial results for the second quarter of 2010.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| James Russell Bell, MD 1100 35th St, Marion, IA 52302-1710 Ph: (319) 377-4844 | James Russell Bell, MD 1100 35th St, Marion, IA 52302-1710 Ph: (319) 377-4844 |
News Archive
Mary Ellen Stanton, a senior maternal health advisor at USAID, and Chris Thomas, global health communications and policy advisor at USAID, outline the agency's work to promote better health outcomes for women and children in the developing world on GlobalPost's "Global Pulse" blog.
Patients with chemotherapy-refractory small-cell lung cancer may benefit from treatment with the topoisomerase II inhibitor amrubicin, research from Japan suggests.
IMDx today announced that they have signed a multi-year agreement with Abbott whereby IMDx will design, develop, regulatory clear, and manufacture assays for the Abbott Molecular FDA cleared, m2000 instrument system to be distributed worldwide. Financial terms have not been disclosed.
ARYx Therapeutics, Inc. today announced that it has secured bridge financing to allow ARYx time and resources to potentially complete a transaction that could create significant value for stockholders. ARYx also released its financial results for the second quarter of 2010.
› Verified 1 days ago
James E Mccabe, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2996 7th Ave, Ste B, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Thomas J Richmann, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1100 35th St, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Julie Hoffmann, NP Family Medicine Medicare: Medicare Enrolled Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-373-3022 Fax: 319-373-0208 | |
Deepti Smitha Kurra, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 2996 7th Ave Ste B, Marion, IA 52302 Phone: 319-377-4844 Fax: 319-377-0852 | |
Arleen Zahn-houser, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-373-8708 Fax: 319-373-8774 | |
Dr. Jaclyn M Price, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 3701 Katz Dr, Marion, IA 52302 Phone: 319-377-3174 Fax: 319-377-9368 | |
Ms. Larae Gail Stemmerman, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 905 29th Ave Ste 120, Marion, IA 52302 Phone: 319-826-6374 Fax: 319-826-6377 |